[시장보고서]식물 유래 API 시장 규모, 점유율 및 동향 분석 보고서 : 분자 유형별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

식물 유래 API 시장 규모, 점유율 및 동향 분석 보고서 : 분자 유형별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Plant-based API Market Size, Share & Trends Analysis Report By Molecule Type (Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin and Stilbenes), By End Use, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1908669

리서치사 : Grand View Research

발행일 : 2025년 12월

페이지 정보 : 영문 150 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,716,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,181,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,111,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

식물 유래 API 시장 요약

세계의 식물 유래 API 시장 규모는 2024년에 317억 8,000만 달러로 추정되며, 2033년까지 532억 1,000만 달러에 이를 것으로 예측됩니다.

또한, 2025-2033년 연평균 5.9%의 성장률을 보일 것으로 예측됩니다. 제약회사들이 강력한 치료적 의미를 지닌 천연 유래 성분으로 전환하는 가운데, 시장은 꾸준히 발전하고 있습니다.

환자와 임상의가 더 깨끗한 불순물 프로파일과 우수한 안전성 결과를 제공하는 식물성 활성 성분에 대한 신뢰가 높아짐에 따라 수요가 증가하고 있습니다. 예를 들어, 2025년 9월 'Current Issues in Molecular Biology'지에 게재된 리뷰에 따르면, 대사공학을 통해 파클리탁셀을 포함한 테르페노이드의 생산량이 25배 증가하고, 설계 시스템에서 아르테미시닌의 수율이 38% 향상되었습니다는 보고가 있었습니다. 보고된 바 있습니다. 유전체학, 전사체학, 대사체학 등 멀티오믹스 기법을 통해 주요 생합성 유전자와 조절 네트워크가 밝혀졌습니다. 한편, CRISPR 도구, 효소공학, 세포 내 표적화 기술을 통해 건조 중량 기준 0.05% 이하로 낮은 자연 수율을 해결할 수 있게 되었습니다.

본 리뷰에서는 대사 플럭스의 균형화, 세포 독성, 스케일업 비용 등의 과제를 강조하고, 실험실 규모의 테르페노이드 생산을 산업적 생산으로 전환하기 위한 로드맵을 제시하였습니다. 이러한 관심에 따라 제조업체들은 추출 및 정제 시스템을 고도화하여 생산 배치 간 균일한 효능과 규제 준수를 보장하기 위해 노력하고 있습니다. 제약사들은 만성질환 및 생활습관병을 대상으로 하는 식물 유래 화합물을 특징으로 하는 파이프라인을 강화하고 있으며, 이를 통해 시장에서 지속적인 모멘텀을 확보해 나가고 있습니다. 또한, 안정적인 원료 공급을 보장하는 확장 가능한 재배 네트워크가 산업을 뒷받침하고 있으며, 생산자는 지속적인 생산을 유지하여 세계 시장에 안정적인 공급을 실현할 수 있습니다.

지역별 시장 점유율 분석, 2024년 및 2033년
지역별 시장 대시보드
시장 규모와 예측 동향 분석, 2021-2033년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제7장 경쟁 구도

참가 기업 개요
기업 시장 현황 분석
기업 분류
전략 매핑
기업 개요/리스트
- Roquette Freres
- Arboris
- Centroflora
- BASF SE
- Kothari Phytochemicals &Industries Ltd.
- Evonik Industries AG
- Brains(Brains Bioceutical)
- Indo Phytochem Pharmaceuticals.
- HimPharm.com.
- Cargill, Incorporated

LSH

영문 목차

영문목차

Plant-based API Market Summary

The global plant-based API market size was estimated at USD 31.78 billion in 2024 and is projected to reach USD 53.21 billion by 2033, growing at a CAGR of 5.9% from 2025 to 2033. The market is progressing steadily as pharmaceutical companies shift toward natural-origin ingredients supported by strong therapeutic relevance.

Demand is increasing as patients and clinicians show greater confidence in botanical actives that deliver cleaner impurity profiles and favorable safety outcomes. For instance, in September 2025, Current Issues in Molecular Biology published a review describing how metabolic engineering raised terpenoid production, including paclitaxel, by 25-fold and enhanced artemisinin yield by 38% in engineered systems. Multi-omics approaches, including genomics, transcriptomics, and metabolomics, revealed key biosynthetic genes and regulatory networks. Meanwhile, CRISPR tools, enzyme engineering, and subcellular targeting addressed the low natural yields, which often fall below 0.05% dry weight.

The review highlighted challenges such as metabolic flux balancing, cytotoxicity, and scale-up costs, proposing a roadmap to translate lab-scale terpenoid production into industrial manufacturing. This growing interest is encouraging manufacturers to upgrade extraction and purification systems that ensure uniform potency and regulatory compliance across production batches. Drug developers are strengthening pipelines that feature phyto-derived compounds for chronic and lifestyle-driven conditions, which helps establish consistent market momentum. The industry is further supported by scalable cultivation networks that secure dependable raw material availability, allowing producers to maintain continuous output and deliver a stable supply across global markets.

Global Plant-based API Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global plant-based API market report based on molecule type, end use, and region:

Molecule Type Outlook (Revenue, USD Million, 2021 - 2033)
Alkaloids
Anthocyanin
Flavonoids
Phenolic Acids
Terpenoids
Lignin and Stilbenes
Others
End UseOutlook (Revenue, USD Million, 2021 - 2033)
Pharmaceuticals
Nutraceuticals
Herbal Based Industries
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Molecule Type
- 1.2.2. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Plant-based API Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrants
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
- 3.3.3. Pipeline Analysis
- 3.3.4. Patent Expiry Analysis
- 3.3.5. Pricing Analysis

Chapter 4. Plant-based API Market: Molecule Type Business Analysis

4.1. Molecule Type Market Share, 2024 & 2033
4.2. Molecule Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Molecule Type, 2021 to 2033 (USD Million)
4.4. Alkaloids
- 4.4.1. Alkaloids Market, 2021 - 2033 (USD Million)
4.5. Anthocyanin
- 4.5.1. Anthocyanin Market, 2021 - 2033 (USD Million)
4.6. Flavonoids
- 4.6.1. Flavonoids Market, 2021 - 2033 (USD Million)
4.7. Phenolic Acids
- 4.7.1. Phenolic Acids Market, 2021 - 2033 (USD Million)
4.8. Terpenoids
- 4.8.1. Terpenoids Market, 2021 - 2033 (USD Million)
4.9. Lignin and Stilbenes
- 4.9.1. Lignin and Stilbenes Market, 2021 - 2033 (USD Million)
4.10. Others
- 4.10.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Plant-based API Market: End Use Business Analysis

5.1. End Use Market Share, 2024 & 2033
5.2. End Use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by end use, 2021 to 2033 (USD Million)
5.4. Pharmaceuticals
- 5.4.1. Pharmaceuticals Market, 2021 - 2033 (USD Million)
5.5. Nutraceuticals
- 5.5.1. Nutraceuticals Market, 2021 - 2033 (USD Million)
5.6. Herbal Based Industries
- 5.6.1. Herbal Based Industries Market, 2021 - 2033 (USD Million)
5.7. Others
- 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Plant-based API Market: Regional Estimates & Trend Analysis

6.1. Regional Market Share Analysis, 2024 & 2033
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
6.4. North America
- 6.4.1. North America Plant-based API Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 6.4.2. U.S.
  - 6.4.2.1. Key Country Dynamics
  - 6.4.2.2. Target Disease Prevalence
  - 6.4.2.3. Regulatory Framework
  - 6.4.2.4. Reimbursement Framework
  - 6.4.2.5. U.S. Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.3. Canada
  - 6.4.3.1. Key Country Dynamics
  - 6.4.3.2. Target Disease Prevalence
  - 6.4.3.3. Regulatory Framework
  - 6.4.3.4. Reimbursement Framework
  - 6.4.3.5. Canada Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4.4. Mexico
  - 6.4.4.1. Key Country Dynamics
  - 6.4.4.2. Target Disease Prevalence
  - 6.4.4.3. Regulatory Framework
  - 6.4.4.4. Reimbursement Framework
  - 6.4.4.5. Mexico Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Europe
- 6.5.1. Europe Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.2. UK
  - 6.5.2.1. Key Country Dynamics
  - 6.5.2.2. Target Disease Prevalence
  - 6.5.2.3. Regulatory Framework
  - 6.5.2.4. Reimbursement Framework
  - 6.5.2.5. UK Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.3. Germany
  - 6.5.3.1. Key Country Dynamics
  - 6.5.3.2. Target Disease Prevalence
  - 6.5.3.3. Regulatory Framework
  - 6.5.3.4. Reimbursement Framework
  - 6.5.3.5. Germany Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.4. France
  - 6.5.4.1. Key Country Dynamics
  - 6.5.4.2. Target Disease Prevalence
  - 6.5.4.3. Regulatory Framework
  - 6.5.4.4. Reimbursement Framework
  - 6.5.4.5. France Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.5. Italy
  - 6.5.5.1. Key Country Dynamics
  - 6.5.5.2. Target Disease Prevalence
  - 6.5.5.3. Regulatory Framework
  - 6.5.5.4. Reimbursement Framework
  - 6.5.5.5. Italy Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.6. Spain
  - 6.5.6.1. Key Country Dynamics
  - 6.5.6.2. Target Disease Prevalence
  - 6.5.6.3. Regulatory Framework
  - 6.5.6.4. Reimbursement Framework
  - 6.5.6.5. Spain Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.7. Denmark
  - 6.5.7.1. Key Country Dynamics
  - 6.5.7.2. Target Disease Prevalence
  - 6.5.7.3. Regulatory Framework
  - 6.5.7.4. Reimbursement Framework
  - 6.5.7.5. Denmark Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.8. Sweden
  - 6.5.8.1. Key Country Dynamics
  - 6.5.8.2. Target Disease Prevalence
  - 6.5.8.3. Regulatory Framework
  - 6.5.8.4. Reimbursement Framework
  - 6.5.8.5. Sweden Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5.9. Norway
  - 6.5.9.1. Key Country Dynamics
  - 6.5.9.2. Target Disease Prevalence
  - 6.5.9.3. Regulatory Framework
  - 6.5.9.4. Reimbursement Framework
  - 6.5.9.5. Norway Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Asia Pacific
- 6.6.1. Asia Pacific Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.2. Japan
  - 6.6.2.1. Key Country Dynamics
  - 6.6.2.2. Target Disease Prevalence
  - 6.6.2.3. Regulatory Framework
  - 6.6.2.4. Reimbursement Framework
  - 6.6.2.5. Japan Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.3. China
  - 6.6.3.1. Key Country Dynamics
  - 6.6.3.2. Target Disease Prevalence
  - 6.6.3.3. Regulatory Framework
  - 6.6.3.4. Reimbursement Framework
  - 6.6.3.5. China Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.4. India
  - 6.6.4.1. Key Country Dynamics
  - 6.6.4.2. Target Disease Prevalence
  - 6.6.4.3. Regulatory Framework
  - 6.6.4.4. Reimbursement Framework
  - 6.6.4.5. India Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.5. Australia
  - 6.6.5.1. Key Country Dynamics
  - 6.6.5.2. Target Disease Prevalence
  - 6.6.5.3. Regulatory Framework
  - 6.6.5.4. Reimbursement Framework
  - 6.6.5.5. Australia Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.6. South Korea
  - 6.6.6.1. Key Country Dynamics
  - 6.6.6.2. Target Disease Prevalence
  - 6.6.6.3. Regulatory Framework
  - 6.6.6.4. Reimbursement Framework
  - 6.6.6.5. South Korea Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6.7. Thailand
  - 6.6.7.1. Key Country Dynamics
  - 6.6.7.2. Target Disease Prevalence
  - 6.6.7.3. Regulatory Framework
  - 6.6.7.4. Reimbursement Framework
  - 6.6.7.5. Thailand Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Latin America
- 6.7.1. Latin America Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7.2. Brazil
  - 6.7.2.1. Key Country Dynamics
  - 6.7.2.2. Target Disease Prevalence
  - 6.7.2.3. Regulatory Framework
  - 6.7.2.4. Reimbursement Framework
  - 6.7.2.5. Brazil Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7.3. Argentina
  - 6.7.3.1. Key Country Dynamics
  - 6.7.3.2. Target Disease Prevalence
  - 6.7.3.3. Regulatory Framework
  - 6.7.3.4. Reimbursement Framework
  - 6.7.3.5. Argentina Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Middle East and Africa
- 6.8.1. Middle East and Africa Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8.2. South Africa
  - 6.8.2.1. Key Country Dynamics
  - 6.8.2.2. Target Disease Prevalence
  - 6.8.2.3. Regulatory Framework
  - 6.8.2.4. Reimbursement Framework
  - 6.8.2.5. South Africa Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8.3. Saudi Arabia
  - 6.8.3.1. Key Country Dynamics
  - 6.8.3.2. Target Disease Prevalence
  - 6.8.3.3. Regulatory Framework
  - 6.8.3.4. Reimbursement Framework
  - 6.8.3.5. Saudi Arabia Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8.4. UAE
  - 6.8.4.1. Key Country Dynamics
  - 6.8.4.2. Target Disease Prevalence
  - 6.8.4.3. Regulatory Framework
  - 6.8.4.4. Reimbursement Framework
  - 6.8.4.5. UAE Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8.5. Kuwait
  - 6.8.5.1. Key Country Dynamics
  - 6.8.5.2. Target Disease Prevalence
  - 6.8.5.3. Regulatory Framework
  - 6.8.5.4. Reimbursement Framework
  - 6.8.5.5. Kuwait Plant-based API Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
- 7.5.1. Roquette Freres
  - 7.5.1.1. Overview
  - 7.5.1.2. Financial Performance
  - 7.5.1.3. Product Benchmarking
  - 7.5.1.4. Strategic Initiatives
- 7.5.2. Arboris
  - 7.5.2.1. Overview
  - 7.5.2.2. Financial Performance
  - 7.5.2.3. Product Benchmarking
  - 7.5.2.4. Strategic Initiatives
- 7.5.3. Centroflora
  - 7.5.3.1. Overview
  - 7.5.3.2. Financial Performance
  - 7.5.3.3. Product Benchmarking
  - 7.5.3.4. Strategic Initiatives
- 7.5.4. BASF SE
  - 7.5.4.1. Overview
  - 7.5.4.2. Financial Performance
  - 7.5.4.3. Product Benchmarking
  - 7.5.4.4. Strategic Initiatives
- 7.5.5. Kothari Phytochemicals & Industries Ltd.
  - 7.5.5.1. Overview
  - 7.5.5.2. Financial Performance
  - 7.5.5.3. Product Benchmarking
  - 7.5.5.4. Strategic Initiatives
- 7.5.6. Evonik Industries AG
  - 7.5.6.1. Overview
  - 7.5.6.2. Financial Performance
  - 7.5.6.3. Product Benchmarking
  - 7.5.6.4. Strategic Initiatives
- 7.5.7. Brains (Brains Bioceutical)
  - 7.5.7.1. Overview
  - 7.5.7.2. Financial Performance
  - 7.5.7.3. Product Benchmarking
  - 7.5.7.4. Strategic Initiatives
- 7.5.8. Indo Phytochem Pharmaceuticals.
  - 7.5.8.1. Overview
  - 7.5.8.2. Financial Performance
  - 7.5.8.3. Product Benchmarking
  - 7.5.8.4. Strategic Initiatives
- 7.5.9. HimPharm.com.
  - 7.5.9.1. Overview
  - 7.5.9.2. Financial Performance
  - 7.5.9.3. Product Benchmarking
  - 7.5.9.4. Strategic Initiatives
- 7.5.10. Cargill, Incorporated
  - 7.5.10.1. Overview
  - 7.5.10.2. Financial Performance
  - 7.5.10.3. Product Benchmarking
  - 7.5.10.4. Strategic Initiatives

한글목차

식물 유래 API 시장 요약

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 식물 유래 API 시장 변수, 동향 및 범위

제4장 식물 유래 API 시장 : 분자 유형별 비즈니스 분석

제5장 식물 유래 API 시장 : 최종 용도별 비즈니스 분석

제6장 식물 유래 API 시장 : 지역별 추정·동향 분석